On October 31, 2025, the 9th Oriental Congress of Urology and Andrology (OCUA2025) grandly opened at the Shanghai International Conference Center. During the opening ceremony, academician Zhang Xu from the Chinese Academy of Sciences and chairman of the Urology and Andrology Branch of the Chinese Medical Association delivered a speech, emphasizing the need for the urology and andrology fields to focus on clinical demands, strengthen technological innovation, and foster multidisciplinary collaboration to drive the discipline towards precision and minimally invasive treatment. Professor Wu Jinglei, Vice Chairman of the Shanghai Association for Science and Technology and President of the Shanghai Medical Association, noted that the OCUA series of conferences has become a vital academic platform in Asia for urology and andrology, and expressed hopes for this conference to promote exchanges between experts worldwide and support Shanghai's development as a high-level medical academic hub.

After the opening ceremony, the conference also held an award ceremony for outstanding young papers, recognizing innovative research achievements in the field and encouraging young scholars to engage in both basic and clinical research in urology and andrology, injecting continuous vitality into the development of the discipline.

As a representative enterprise in the field of andrology treatment technology innovation, WBL Medical Group showcased several self-developed core products at Booth B04, demonstrating their technological achievements and clinical transformation capabilities to the industry.

Core Technological Achievements Showcased by WBL

WBL Medical Group's highlight at this year's conference is the LIPUS Low-Intensity Pulsed Ultrasound ED Treatment Device, which, with its innovative non-invasive energy focusing technology, has won the prestigious IDEA Award in international design. This device precisely adjusts ultrasound parameters to directly target the local tissues of erectile dysfunction (ED) patients, effectively improving blood circulation and promoting tissue repair. Compared to traditional treatments, the LIPUS device offers significant advantages, including being non-invasive, safe, and efficient, providing a more optimized treatment option for patients, especially those who have concerns about medication or surgery.

For chronic pelvic pain syndrome (CPPS) and pelvic floor dysfunction, WBL Medical Group has launched the next-generation extracorporeal pulsed ultrasound pelvic floor treatment platform. This platform uses customized energy output and an intelligent temperature control system to achieve non-invasive, personalized pelvic muscle repair. Its core advantages include:

1.Precise Treatment: Energy parameters are dynamically adjusted according to the patient's condition, ensuring maximum treatment effectiveness.

2.Non-invasive Experience: It avoids surgical trauma, reducing the risk of complications.

3.Intelligent Temperature Control: Real-time monitoring of the treatment area’s temperature ensures treatment safety.

This innovative platform provides a more comfortable and efficient treatment option for pelvic floor dysfunction patients, significantly improving their quality of life.

WBL LIPUS Technology Principles and Treatment Effects

The core mechanism of WBL LIPUS involves using low-energy pulsed ultrasound (sound intensity range: 50-350 mW/CM²) on the penile cavernous body tissues, activating endogenous stem cells, promoting vascular and nerve regeneration, and repairing damaged vascular endothelium and nerve matrix. This treatment method improves erectile function from a pathological level. Compared to traditional oral medications (such as PDE5 inhibitors), prosthetic implants, or invasive therapies (such as intracavernous injections), WBL LIPUS provides a safe, non-invasive treatment option without the dependence and side effects associated with medications or the surgical complications tied to other treatments.

Competitive Advantages of WBL LIPUS

1.Non-invasiveness and Safety

No need for medications or surgery, avoiding the burden on the liver and kidneys and reducing infection risks, especially suitable for patients with chronic diseases such as diabetes.

2.Comprehensive Treatment Approach

The unique “LIPUS + Psychological Counseling + VR” multidimensional therapy combines physiological repair with psychological intervention, enhancing patient satisfaction by over 30%.

3.Clinical Data

Supported by clinical validation from more than 60 medical institutions globally, with its efficacy and safety endorsed by authoritative institutions such as UCSF and Peking University Hospital.

Technological Strength: Dual Assurance in Quality Control and Clinical Validation

WBL Medical Group consistently adheres to a clinical demand-oriented approach, ensuring the safety and effectiveness of every product through a rigorous quality control system and multi-center clinical validation. The products on display have been supported by extensive clinical data, and their technological achievements have been highly recognized by domestic and international experts, fully reflecting WBL's technological accumulation and clinical transformation capabilities in the andrology treatment field.

We invite you to visit Booth B04 and discuss the future of andrology diagnosis and treatment with WBL Medical Group!

OCUA2025 has provided a high-end academic exchange platform for the field of urology and andrology, and WBL Medical Group looks forward to in-depth communication with colleagues from around the world at Booth B04, working together to drive innovation in andrology treatment technology and clinical applications.